Alternating electric tumor treating fields for treatment of glioblastoma: rationale, preclinical, and clinical studies

LTBK-01: PROSPECTIVE, MULTI-CENTER PHASE III TRIAL OF TUMOR TREATING FIELDS TOGETHER WITH TEMOZOLOMIDE COMPARED TO TEMOZOLOMIDE ALONE IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA

(2016) Roger Stupp et al.   NEURO-ONCOLOGY

The cost-effectiveness of tumor-treating fields therapy in patients with newly diagnosed glioblastoma

(2016) F. Bernard-Arnoux et al.   NEURO-ONCOLOGY

The molecular genetics and tumor pathogenesis of meningiomas and the future directions of meningioma treatments

(2016) Winward Choy et al.   Neurosurgical Focus

Maintenance Therapy With Tumor-Treating Fields Plus Temozolomide vs Temozolomide Alone for Glioblastoma

(2015) Roger Stupp et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Economic Evaluation of Bevacizumab for the First-Line Treatment of Newly Diagnosed Glioblastoma Multiforme

(2015) Bruno Kovic et al.   JOURNAL OF CLINICAL ONCOLOGY

Tumor Treating Fields Perturb the Localization of Septins and Cause Aberrant Mitotic Exit

(2015) Nidhi Gera et al.   PLoS One

NovoTTF™-100A System (Tumor Treating Fields) transducer array layout planning for glioblastoma: a NovoTAL™ system user study

(2015) Aafia Chaudhry et al.   World Journal of Surgical Oncology

Mitotic Spindle Disruption by Alternating Electric Fields Leads to Improper Chromosome Segregation and Mitotic Catastrophe in Cancer Cells

(2015) Moshe Giladi et al.   Scientific Reports

NT-40 * Interim Analysis of the EF-14 Trial: A Prospective, Multi-center Trial of NovoTTF-100A Together With Temozolomide Compared to Temozolomide Alone in Patients with Newly Diagnosed GBM

(2014) R. Stupp et al.   NEURO-ONCOLOGY

Targeting adaptive glioblastoma: an overview of proliferation and invasion

(2014) Q. Xie et al.   NEURO-ONCOLOGY

Characterization and Management of Dermatologic Adverse Events With the NovoTTF-100A System, a Novel Anti-mitotic Electric Field Device for the Treatment of Recurrent Glioblastoma

(2014) Mario E. Lacouture et al.   SEMINARS IN ONCOLOGY

The effect of field strength on glioblastoma multiforme response in patients treated with the NovoTTF™-100A system

(2014) Scott G Turner et al.   World Journal of Surgical Oncology

Dose-Dense Temozolomide for Newly Diagnosed Glioblastoma: A Randomized Phase III Clinical Trial

(2013) Mark R. Gilbert et al.   JOURNAL OF CLINICAL ONCOLOGY

A phase I/II trial of Tumor Treating Fields (TTFields) therapy in combination with pemetrexed for advanced non-small cell lung cancer

(2013) Miklos Pless et al.   LUNG CANCER

NovoTTF-100A versus physician’s choice chemotherapy in recurrent glioblastoma: A randomised phase III trial of a novel treatment modality

(2012) Roger Stupp et al.   EUROPEAN JOURNAL OF CANCER

TTFields alone and in combination with chemotherapeutic agents effectively reduce the viability of MDR cell sub-lines that over-express ABC transporters

(2010) Rosa S Schneiderman et al.   BMC CANCER

Alternating electric fields (TTFields) inhibit metastatic spread of solid tumors to the lungs

(2009) Eilon D. Kirson et al.   CLINICAL & EXPERIMENTAL METASTASIS

A Pilot Study with Very Low-Intensity, Intermediate-Frequency Electric Fields in Patients with Locally Advanced and/or Metastatic Solid Tumors

(2008) Marc Salzberg et al.   ONKOLOGIE